Skip to main content
Erschienen in: BMC Public Health 1/2021

Open Access 01.12.2021 | Research article

Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005–2017

verfasst von: Nicola Chiwandire, Nompumelelo Zungu, Musawenkosi Mabaso, Charles Chasela

Erschienen in: BMC Public Health | Ausgabe 1/2021

Abstract

Background

Many people are now living longer with HIV due to access to antiretroviral treatment. In turn, there has been an increase in the burden of hypertension and diabetes. The paucity of data on the burden of hypertension and diabetes in adults living with HIV in South Africa is a public health concern. The paper aimed to describe the prevalence and factors associated with hypertension and diabetes among adults living with HIV (ALHIV).

Methods

This was a secondary data analysis of the population based on the South African National HIV Prevalence, Incidence, Behaviour and Communication surveys for 2005, 2008 and 2017. Descriptive statistics were used to summarise the characteristics of the study sample. Bivariate and multivariate logistic regression analyses were used to determine factors associated with hypertension and diabetes.

Results

The total study population of ALHIV aged 25 years and older was 978, 1023 and 2483 for 2005, 2008 and 2017. The prevalence of hypertension showed an increasing trend at 11.8% in 2005, 9.5% in 2008 and 14.3% in 2017. The prevalence of diabetes was 3.3% in 2005, 2.8% in 2008 and 3.2% in 2017. Increased odds of hypertension among adults living with HIV were consistently associated with being female and the age group 45 years older across all the survey years, including pensioners and the sick, living in urban areas, high risk of hazardous alcohol consumption, diabetes and heart disease. Increased odds of diabetes were consistently associated with hypertension across all the survey years, including age group 45 years and older, and poor health. While having a secondary level of education and above was protective against diabetes.

Conclusion

The study showed that the prevalence of hypertension is high and has increased over time among adults living with HIV while the prevalence of diabetes has remained constant. Findings identified factors consistently associated with the prevalence of both diseases overtime, including contemporary risk factors that should be targeted in the integrated management of chronic disease and HIV care model.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12889-021-10502-8.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ALHIV
Adults living with HIV
ART
Antiretroviral Therapy
AUDIT
Alcohol Use Disorder Identification Test
CDC
Centers for Disease Control and Prevention
CI
Confidence Interval
HIV
Human immunodeficiency virus
HSRC
Human Sciences Research Council
IDF
International Diabetes Federation
NCDs
Non-communicable diseases
OR
Odds ratios
PLHIV
People Living with HIV
REC
Research Ethics Committee
SABSSM
South African National HIV Prevalence, Incidence, Behaviour and Communication survey
SANHANES
South African National Health and Nutrition Examination Survey
WHO
World Health Organization

Background

At 7.9 million, South Africa has the largest population of people living with HIV (PLHIV) in the world [1, 2]. The successful roll-out of the anti-retroviral therapy (ART) programme since 2004 has contributed to improvements in the life expectancy and viral load suppression in PLHIV; and deaths due to opportunistic infections have also declined [3, 4]. This has transformed HIV infection into a chronic disease and evidence shows that as a consequence of a combination of factors including ageing, being on ART, HIV infection and certain lifestyle choices, their risk of developing non-communicable diseases (NCDs) including hypertension or diabetes increases [5]. In addition, the growing double burden of the HIV and NCD co-epidemics has put significant pressure not only on the affected individuals but also on the struggling health system, existing health programmes and the economy in South Africa [610].
Studies that have been done to characterise the burden of hypertension and diabetes in PLHIV highlight the implication of not only collecting prevalence estimates but also adequately addressing multimorbidity in PLHIV and ensuring adequate availability of treatment to reduce the risk [7]. However, these studies present varied findings, suggesting that results and conclusions may not necessarily be extrapolated from one country to the next and not one intervention fits all [1118]. A meta-analysis and systematic review across sub-Saharan Africa reported prevalence estimates for hypertension in PLHIV ranging between 5.2 and 50.0% and that of diabetes to range between 0.5 and 36.6%. In South Africa, studies have also reported prevalence estimates in PLHIV for hypertension as high as 38.6% and diabetes as high as 8.66% [19, 20]. However, these estimates cannot be generalised to the entire South African population. Common risk factors of these NCDs in PLHIV have also been reported to include ageing, family history, use of ART, HIV infection, urbanisation, alcohol drinking and high body mass index in studies conducted in Ethiopia, Nigeria, Malawi, Tanzania, Zimbabwe and South Africa [13, 2127]. Also, further studies indicated that hypertension and diabetes can also act as risk factors of each other [12].
Improved understanding of the magnitude of hypertension and diabetes and associated factors among PLHIV in South Africa is vital for informing public health interventions in the country. This paper investigates trends, prevalence and associated factors of hypertension and diabetes among adults living with HIV (ALHIV) in South Africa using the 2005, 2008, 2012, and 2017 nationally representative population-based HIV Prevalence, Incidence, Behaviour and Communication Surveys.

Methodology

Study design and sample

This secondary analysis utilised data collected from the South African National HIV Prevalence, Incidence, Behaviour, and Communication (SABSSM) surveys in 2005, 2008 and 2017. This was a multi-stage stratified cluster randomised cross-sectional population-based survey undertaken by the Human Sciences Research Council (HSRC). The details of the study and sampling method are described in detail elsewhere [1, 2830]. Briefly, in the 2005 and 2008 surveys, in each household a maximum of three people were selected randomly to participate in the study, each representing the 2–14 years, 15–24 years and 25 years and older age groups [28, 29]. In the 2012 and 2017 surveys, all household members were eligible to participate in the survey [1, 30]. The analysis for this paper was restricted to ALHIV aged 25 years and older who responded to the questions on the primary outcomes, hypertension and diabetes.

Study variables

The primary outcome variables were hypertension and diabetes. These variables were self-reported by the survey participants when asked the question “Do you currently have any of the following illnesses?”. Both outcome variables were coded 1 for the answer “yes”, and 0 for the answer “no”. The explanatory variables used in this study were grouped into three categories namely socio-demographic, behavioural and health-related factors. The socio-demographic factors included sex (male and female), age (25–34 yrs., 35–44 yrs. and 45+ yrs.), race (Non- Black African including White, Coloured and Indian; and Black African), marital status (never married and ever married), employment status (unemployed, employed and other (incl. Old age pensioner, sick/disabled and unable to work), educational level (no or up to primary and secondary and above), locality type (urban, urban formal, urban informal, tribal area/rural informal and rural formal) and province. The behavioural factors included hazardous alcohol consumption using the Alcohol Use Disorders Identification Test score (no risk (do not drink alcohol), low risk (0–7), medium risk (8–15), high risk (16–19) and addiction likely (20–40). Hazardous alcohol consumption was defined as a habit or amount of alcohol intake that raises the risk of adverse health effects [31]. The health-related factors included the exposure to ARVs (ARV exposed, ARV naive), viral load suppressed, perception of general health (excellent, good, fair, and poor), cancer, mental distress, tuberculosis, heart disease, diabetes and health care access (public care, and private care).

Statistical analysis

All analyses were adjusted for complex survey design, clustering and any bias due to non-response using sample weights and the svyset and svy commands in STATA version 15 [32]. Frequency tables with percentages and median with interquartile ranges (IQR) were used to describe the characteristics of the study sample and trends in the prevalence of hypertension and diabetes in the study population. Pearson’s chi-squared test was used for comparison of categorical variables. Bivariate logistic regression analysis was done and explanatory variables that had a p-value < 0.25 were included in the multivariate logistic regression model to determine the associated factors. The Wald test was used to keep variables that had a p-value < 0.05 through a process of removing, refitting, and verifying until all significant variables were kept in the final main effects model. Variables which had very wide confidence intervals were removed from the model regardless of the p-value. The Variance Inflation Factor test was done to check for multicollinearity at a cut off level of 5. A post-estimation test using the Hosmer-Lemeshow Goodness of Fit (GOF) test was done to test whether the final model was a good fit [33]. If the GOF test failed multiple times, the preliminary final model was used instead. Crude and adjusted odds ratios (aOR), 95% confidence intervals (CI) and p-values ≤0.05 are reported to indicate the level of significance.

Results

A total of 978, 1023 and 2483 study participants aged 25 years and older were included for 2005, 2008 and 2017 respectively. Of these, the overall prevalence of hypertension was 11.8% in 2005, 9.5% in 2008 and 14.3% in 2017. While the overall prevalence of diabetes was 3.3% in 2005, 2.8% in 2008 and 3.2% in 2017 (Tables 1 and 2). There was an increase in the trend of hypertension over the 3 years, whereas that of diabetes remained stagnant. The median age (IQR) for those who were hypertensive increased over the period from 37 (33–47) years in 2005, to 44 (34–50) years in 2008 and 48 (38–55) years in 2017 (Table 1). The median age for diabetes also increased from 35 (29–44) years in 2005 to 47 (37–53) years in 2008 and 49 (42–57) years in 2017. Additionally, there was a decreased trend in hypertension and diabetes in the 25–34 age group over the 3 years, while the trend in the 45+ years age group increased.
Table 1
Sociodemographic characteristics and hypertension among ALHIV 25 years and older by survey year for 2005, 2008 and 2017 in South Africa
 
2005
2008
2017
Population characteristics
Hypertension
No hypertension
p-value
Hypertension
No hypertension
p-value
Hypertension
No hypertension
p-value
Overall
126 (11.8%)
820 (88.2%)
 
107 (9.5%)
859 (90.5%)
 
372 (14.3%)
1955 (85.7%)
 
Sex
 Female
97 (13.9%)
542 (86.1%)
0.057
93 (12.8%)
578 (87.2%)
< 0.001
289 (16.6%)
1365 (83.4%)
< 0.001
 Male
29 (8.2%)
278 (91.8%)
14 (3.0%)
281 (97.0%)
83 (10.1%)
590 (89.9%)
Age
 Median (IQR)
37 (33–47)
34 (29–39)
 
44 (34–50)
34 (29–39)
 
48 (38–55)
36 (31–44)
 
 25–34 years
30 (8.6%)
396 (91.4%)
0.009
21 (4.9%)
396 (95.1%)
< 0.001
48 (5.8%)
761 (94.3%)
< 0.001
 35–44 years
37 (12.0%)
288 (88.0%)
31 (7.9%)
296 (92.1%)
84 (9.8%)
647 (90.2%)
 45+ years
59 (21.3%)
136 (78.7%)
55 (26.1%)
167 (73.7%)
240 (30.6%)
547 (69.4%)
Race
 Non-Black African
15 (10.4%)
65 (89.6%)
0.757
4 (13.9%)
54 (86.1%)
0.476
41 (20.3%)
153 (79.7%)
0.087
 Black African
111 (11.8%)
754 (88.2%)
103 (9.4%)
805 (90.6%)
331 (14.1%)
1802 (85.9%)
Marital status
 Never married
41 (9.5%)
437 (90.5%)
0.121
54 (8.5%)
524 (91.6%)
0.154
192 (11.9%)
1288 (88.1%)
< 0.001
 Ever married
84 (14.3%)
380 (85.7%)
53 (11.7%)
332 (88.3%)
180 (18.9%)
667 (81.1%)
Highest educational qualification
 None or Primary
68 (15.1%)
315 (84.9%)
0.147
56 (13.4%)
274 (86.6%)
0.072
101 (18.9%)
441 (81.1%)
0.002
 Secondary and above
58 (9.74%)
503 (90.3%)
50 (8.0%)
580 (92.0%)
199 (12.3%)
1253 (87.7%)
Employment status
 Unemployed
59 (9.9%)
462 (90.1%)
0.108
54 (9.9%)
423 (90.1%)
0.314
249 (15.4%)
1199 (84.6%)
< 0.001
 Employed
40 (13.0%)
291 (87.0%)
34 (7.9%)
345 (92.1%)
99 (11.0%)
718 (89.0%)
 Other
26 (20.3%)
64 (79.7%)
19 (13.4%)
90 (86.6%)
23 (33.7%)
37 (66.3%)
Locality
 Urban formal
57 (12.7%)
326 (87.3%)
0.491
47 (12.4%)
323 (87.6%)
0.072
236 (15.9%)
1027 (84.1%)
0.008
 Urban informal
34 (14.2%)
180 (85.8%)
30 (10.3%)
208 (89.7%)
 Tribal area/Rural informal
28 (10.7%)
239 (89.3%)
25 (6.1%)
238 (93.9%)
99 (11.6%)
636 (88.4%)
 Rural formal
7 (6.2%)
75 (93.8%)
5 (5.9%)
90 (94.1%)
37 (10.1%)
292 (89.9%)
Hazardous alcohol consumption
 No risk
88 (13.2%)
558 (86.8%)
0.085
73 (9.7%)
574 (90.3%)
 
261 (14.1%)
1359 (85.9%)
 
 Low risk
24 (6.7%)
175 (93.3%)
25 (11.4%)
181 (88.6%)
0.230
83 (16.8%)
407 (83.2%)
0.078
 Medium risk
12 (16.4%)
52 (83.6%)
6 (5.2%)
62 (94.8%)
13 (7.1%)
137 (92.9%)
 High risk
1 (5.5%)
11 (94.5%)
1 (1.2%)
15 (98.8%)
8 (22.6%)
23 (77.4%)
 Addiction likely
1 (4.4%)
11 (95.6%)
1 (1.7%)
12 (98.3%)
4 (9.3%)
25 (90.7%)
Exposure to ARVs
 ARV exposed
      
234 (15.1%)
1150 (84.9%)
0.478
 ARV naive
      
107 (13.0%)
600 (87.0%)
Viral load suppressed
 Yes
      
254 (15.9%)
1231 (84.1%)
0.033
 No
      
116 (11.9%)
703 (88.1%)
Perception of general health
 Excellent
5 (7.3%)
88 (92.7%)
0.003
5 (2.2%)
161 (97.8%)
0.006
42 (10.0%)
371 (90.0%)
< 0.001
 Good
55 (9.0%)
498 (91.0%)
48 (9.9%)
444 (90.1%)
186 (13.2%)
1134 (86.8%)
 Fair
50 (19.3%)
182 (80.7%)
43 (14.5%)
194 (85.5%)
105 (18.4%)
370 (81.6%)
 Poor
15 (22.9%)
51 (77.1%)
11 (10.0%)
59 (90.0%)
39 (27.1%)
78 (72.9%)
Diabetes
 Yes
20 (56.1%)
14 (43.9%)
< 0.001
17 (54.0%)
10 (46.0%)
< 0.001
49 (52.7%)
35 (47.3%)
< 0.001
 No
103 (10.3%)
804 (89.7%)
88 (7.7%)
849 (92.3%)
322 (13.1%)
1919 (86.9%)
Heart disease
 Yes
   
7 (28.8%)
12 (71.2%)
0.008
23 (41.8%)
25 (58.2%)
< 0.001
 No
   
99 (8.7%)
845 (91.3%)
346 (13.6%)
1922 (86.4%)
Cancer
 Yes
3 (54.5%)
2 (45.5%)
0.009
3 (65.5%)
3 (34.5%)
< 0.001
4 (66.2%)
4 (33.8%)
< 0.001
 No
120 (11.5%)
816 (88.5%)
102 (8.8%)
855 (91.2%)
365 (14.2%)
1946 (85.8%)
Mental distress
 Yes
71 (18.2%)
327 (81.8%)
0.004
5 (8.6%)
31 (91.4%)
0.951
128 (16.1%)
512 (83.9%)
0.230
 No
53 (7.52%)
491 (92.5%)
99 (8.9%)
826 (91.1%)
244 (13.7%)
1443 (86.3%)
Tuberculosis
 Yes
9 (15.4%)
54 (84.6%)
0.467
5 (7.6%)
44 (92.5%)
0.757
16 (19.5%)
60 (80.5%)
0.257
 No
114 (11.5%)
766 (88.5%)
100 (9.0%)
815 (91.0%)
352 (14.1%)
1891 (85.9%)
Health care access
 Public
109 (12.7%)
675 (87.3%)
0.113
90 (10.6%)
649 (89.4%)
0.104
337 (14.7%)
1766 (85.3%)
0.296
 Private
15 (7.1%)
122 (92.9%)
15 (6.3%)
186 (93.7%)
35 (12.7%)
164 (87.3%)
Table 2
Sociodemographic characteristics and diabetes among ALHIV 25 years and older by survey year for 2005, 2008 and 2017 in South Africa
 
2005
2008
2017
Population characteristics
Diabetes
No diabetes
p-value
Diabetes
No diabetes
p-value
Diabetes
No diabetes
p-value
Overall
34 (3.3%)
907 (96.7%)
 
29 (2.8%)
937 (97.2%)
 
87 (3.2%)
2242 (96.8%)
 
Sex
 Female
22 (2.5%)
614 (97.5%)
0.198
26 (3.5%)
645 (96.5%)
0.227
63 (3.6%)
1592 (96.4%)
0.208
 Male
12 (4.5%)
293 (95.5%)
3 (1.5%)
292 (98.5%)
24 (2.5%)
650 (97.5%)
Age
 Median (IQR)
35 (29–44)
34 (29–40)
 
47 (37–53)
34 (29–40)
 
49 (42–57)
37 (32–46)
 
 25–34 years
10 (3.1%)
415 (96.9%)
0.866
5 (1.1%)
411 (98.9%)
< 0.001
4 (0.7%)
804 (99.3%)
< 0.001
 35–44 years
12 (3.1%)
312 (96.9%)
9 (2.2%)
317 (97.8%)
21 (2.8%)
710 (97.2%)
 45+ years
12 (4.1%)
180 (95.9%)
15 (9.2%)
209 (90.8%)
62 (6.8%)
728 (93.2%)
Race
 Non-Black African
3 (0.9%)
76 (99.1%)
0.030
3 (8.0%)
55 (92.0%)
0.103
10 (5.6%)
183 (94.4%)
0.184
 Black African
31 (3.3%)
830 (96.7%)
26 (2.7%)
882 (97.3%)
77 (3.1%)
2059 (96.9%)
Marital status
 Never married
11 (3.2%)
465 (96.8%)
0.944
11 (2.0%)
566 (98.0%)
0.097
38 (2.8%)
1441 (97.2%)
0.250
 Ever married
23 (3.3%)
438 (96.7%)
18 (4.5%)
368 (95.5%)
49 (3.9%)
801 (96.1%)
Highest educational qualification
 None or Primary
12 (3.0%)
370 (97.0%)
0.915
12 (4.5%)
318 (95.5%)
0.157
34 (7.1%)
509 (92.9%)
< 0.001
 Secondary and above
22 (3.5%)
535 (96.5%)
16 (2.2%)
614 (97.9%)
37 (1.7%)
1416 (98.3%)
Employment status
 Unemployed
17 (3.0%)
501 (97.0%)
0.915
17 (2.4%)
460 (97.6%)
0.528
56 (3.4%)
1394 (96.6%)
0.582
 Employed
13 (3.7%)
317 (96.3%)
9 (2.9%)
370 (97.1%)
29 (3.0%)
788 (97.0%)
 Other (incl. Old age pensioner. Sick/disabled and unable to work)
4 (3.4%)
85 (96.6%)
3 (5.0%)
106 (95.0%)
2 (1.4%)
58 (98.6%)
Locality
 Urban formal
18 (4.2%)
361 (95.8%)
0.271
11 (3.1%)
359 (96.9%)
0.797
56 (3.5%)
1209 (96.5%)
0.241
 Urban informal
10 (4.8%)
203 (95.2%)
6 (2.0%)
231 (98.0%)
 Tribal area/Rural informal
6 (2.1%)
261 (97.9%)
9 (2.5%)
255 (97.53%)
24 (2.8%)
711 (97.2%)
 Rural formal
0 (0.0%)
82 (100%)
3 (4.6%)
92 (95.4%)
7 (1.4%)
322 (98.6%)
Hazardous alcohol consumption
 No risk
22 (3.4%)
623 (96.7%)
0.040
22 (3.2%)
625 (96.8%)
0.679
62 (3.2%)
1559 (96.9%)
0.548
 Low risk
5 (1.1%)
191 (98.9%)
5 (1.9%)
201 (98.1)
19 (3.0%)
472 (97.0%)
 Medium risk
6 (9.6%)
57 (90.4%)
0 (0.0%)
68 (100%)
4 (5.3%)
146 (94.7%)
 High risk
0 (0.0%)
12 (100%)
1 (2.4%)
15 (97.6%)
1 (0.2%)
30 (99.8%)
 Addiction likely
1 (6.0%)
11 (94.0%)
0 (0.0%)
13 (100%)
0 (0.0%)
29 (100%)
Exposure to ARVs
 ARV exposed
      
56 (3.2%)
1331 (96.8%)
0.675
 ARV naive
      
26 (3.3%)
680 (96.7%)
 Viral load suppressed
         
 Yes
      
56 (3.0%)
1430 (97.0%)
0.392
 No
      
30 (3.5%)
790 (96.5%)
Perception of general health
 Excellent
1 (1.5%)
92 (98.5%)
0.001
1 (0.9%)
165 (99.1%)
0.031
6 (1.2%)
406 (98.8%)
< 0.001
 Good
14 (1.8%)
537 (98.2%)
10 (2.0%)
481 (98.0%)
42 (2.6%)
1278 (97.5%)
 Fair
15 (8.4%)
214 (91.6%)
15 (6.2%)
223 (93.8%)
22 (4.1%)
457 (95.9%)
 Poor
4 (3.9%)
62 (96.1%)
3 (2.7%)
67 (97.3%)
17 (13.9%)
99 (86.1%)
Hypertension
 Yes
20 (15.6%)
103 (84.4%)
< 0.001
17 (16.1%)
88 (83.9%)
< 0.001
49 (11.3%)
322 (88.7%)
< 0.001
 No
14 (1.6%)
804 (98.4%)
10 (1.4%)
849 (98.7%)
35 (1.7%)
1919 (98.3%)
Heart disease
 Yes
   
5 (22.1%)
15 (77.9%)
< 0.001
4 (5.5%)
44 (94.5%)
0.298
 No
   
23 (2.4%)
920 (97.6%)
83 (3.1%)
2188 (96.9%)
Cancer
 Yes
3 (54.5%)
2 (45.5%)
< 0.001
2 (48.7%)
4 (51.3%)
< 0.001
3 (41.5%)
5 (58.5%)
< 0.001
 No
31 (2.9%)
905 (97.1%)
25 (2.3%)
933 (97.7%)
84 (3.1%)
2230 (96.9%)
Mental distress
 Yes
19 (5.0%)
376 (95.0%)
0.061
3 (8.9%)
33 (91.1%)
0.053
25 (3.4%)
615 (96.6%)
0.789
 No
15 (2.1%)
527 (97.9%)
24 (2.3%)
902 (97.7%)
62 (3.1%)
1627 (96.9%)
Tuberculosis
 Yes
4 (7.4%)
57 (92.6%)
0.134
4 (7.1%)
45 (92.9%)
0.116
8 (5.9%)
68 (94.1%)
0.142
 No
30 (3.0%)
850 (97.0%)
24 (2.5%)
892 (95.5%)
79 (3.1%)
2168 (96.9%)
Health care access
 Public
28 (3.2%)
753 (96.8%)
0.559
21 (2.3%)
719 (97.7%)
0.190
69 (2.8%)
2034 (97.2%)
0.002
 Private
6 (4.4%)
130 (95.6%)
7 (5.1%)
193 (94.9%)
17 (8.1%)
184 (91.9%)
In 2005, 2008 and 2017 females had a higher prevalence of hypertension at 13.9, 12.8 and 16.6% respectively compared to males. Black Africans had the highest prevalence of hypertension at 11.8% in 2005 whereas, non-black Africans had the highest prevalence in 2008 and 2017 with 13.9 and 20.3% respectively. The prevalence estimates for diabetes were as follows: Black Africans with 3.3% in 2005, Non-Black Africans with 8.0% in 2008 and Non-Black Africans with 5.6% in 2017. In 2017, those who were exposed to ARVs had a high prevalence of hypertension at 15.1% and a marginally lower prevalence of diabetes at 3.2% compared to those who were naïve to ARVs (Tables 1 and 2).
The prevalence distribution of hypertension was highest in the KwaZulu Natal province at 37.0% in 2005 and for 2008 and 2017, the Gauteng province had the highest proportion of 27.6 and 30.4% respectively (Fig. 1).
The illustration shows that diabetes was highest in the KwaZulu Natal province in 2005 and 2008 at 25.5 and 28.2% respectively, and in 2017, the Gauteng Province had the highest estimation at 29.4% (Fig. 2).

Factors associated with hypertension

The factors associated with hypertension in 2005 included being female (aOR = 2.59; 95% CI = 1.26 to 5.32), the age group 45+ years (aOR = 4.03; 95% CI = 1.96 to 8.28), those with diabetes (aOR = 11.73; 95% CI = 4.02 to 34.20), and those with mental distress (aOR = 2.97; 95% CI = 1.59 to 5.54) (Table 3). In 2008, factors associated with hypertension included being female (aOR = 4.31; 95% CI = 1.94 to 9.58), the age group 45+ years (aOR = 8.44; 95% CI = 3.92 to 18.15), those who perceived their health to be good (aOR = 3.72; 95% CI = 1.00 to 13.81), those who perceived their health to be fair (aOR = 5.44; 95% CI = 1.40 to 21.12), those who perceived their health to be poor (aOR = 4.82; 95% CI = 1.05 to 22.20), those who lived in an urban formal area (aOR = 2.95; 95% CI = 1.34 to 6.53), those with diabetes (aOR = 6.16; 95% CI = 1.68 to 22.59) and those who accessed public health care services (aOR = 2.58; 95% CI = 1.02 to 6.51) (Table 4). While in 2017 factors associated with hypertension included being female (aOR = 2.33; 95% CI = 1.60 to 3.42), the age group 45+ years (aOR = 7.32; 95% CI = 4.78 to 11.21), pensioners and the sick (aOR = 2.27; 95% CI = 1.09 to 4.73), those who lived in an urban area (aOR = 1.61; 95% CI = 1.16 to 2.23), those who had a high risk of hazardous alcohol consumption (aOR = 4.43; 95% CI = 1.67 to 11.76), those with diabetes (aOR = 5.17; 95% CI = 2.69 to 9.96) and those with heart disease (aOR = 3.36; 95% CI = 1.59 to 7.10) (Table 5).
Table 3
Factors associated with hypertension for 2005
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
1.81 (0.98–3.37)
2.59 (1.26–5.32) *
Age groups
 25–34 years
Reference
Reference
 35–44 years
1.46 (0.73–2.92)
1.72 (0.81–3.64)
 45+ years
2.90 (1.43–5.89) **
4.03 (1.96–8.28) ***
Race
 Non-Black African
Reference
Reference
 Black African
1.15 (0.47–2.85)
0.96 (0.34–2.81)
Hazardous alcohol consumption
 No risk
Reference
Reference
 Low risk
0.47 (0.23–0.95) *
0.56 (0.26–1.24)
 Medium risk
1.28 (0.55–2.98)
1.48 (0.60–3.69)
 High risk
0.38 (0.05–3.18)
0.38 (0.04–3.37)
 Addiction likely
0.29 (0.03–2.44)
0.18 (0.01–2.92)
Diabetes
 No
Reference
Reference
 Yes
11.16 (4.14–30.05) ***
11.73 (4.02–34.20) ***
Mental distress
 No
Reference
Reference
 Yes
2.73 (1.54–4.85) **
2.97 (1.59–5.54) **
*p < 0.05, **p < 0.01, ***p < 0.001
Table 4
Factors associated with hypertension for 2008
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
4.81 (2.10–11.02) ***
4.31 (1.94–9.58) ***
Age groups
 25–34 years
Reference
Reference
 35–44 years
1.68 (0.76–3.71)
2.22 (0.99–4.97)
 45+ years
6.95 (3.34–14.45) ***
8.44 (3.92–18.15) ***
Race
 Non-African
Reference
Reference
 African
0.65 (0.19–2.17)
0.67 (0.14–3.28)
Locality
 Tribal area/Rural informal
Reference
Reference
 Rural formal
0.96 (0.25–3.66)
0.93 (0.35–2.46)
 Urban informal
1.77 (0.90–3.51)
2.40 (1.06–5.43) *
 Urban formal
2.20 (1.13–4.28) *
2.95 (1.34–6.53) **
Hazardous alcohol consumption
 No risk
Reference
Reference
 Low risk
1.20 (0.61–2.36)
1.44 (0.66–3.12)
 Medium risk
0.50 (.018–1.42)
0.78 (0.26–2.35)
 High risk
0.11 (0.01–0.97) *
0.15 (0.01–1.78)
 Addiction likely
0.16 (0.02–1.47)
0.25 (0.03–1.97)
Perception of general health
 Excellent
Reference
Reference
 Good
4.92 (1.49–16.22) **
3.72 (1.00–13.81) *
 Fair
7.56 (2.33–24.58) **
5.44 (1.40–21.12) *
 Poor
4.95 (1.30–18.80) *
4.82 (1.05–22.20) *
Diabetes
 No
Reference
Reference
 Yes
14.03 (5.27–37.35) ***
6.16 (1.68–22.59) **
Heart disease
 No
Reference
Reference
 Yes
4.26 (1.33–13.70) *
1.13 (0.23–5.52)
Health care access
 Private
Reference
Reference
 Public
1.76 (0.88–3.51)
2.58 (1.02–6.51) *
*p < 0.05, **p < 0.01, ***p < 0.001
Table 5
Factors associated with hypertension for 2017
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
1.76 (1.29–2.41) ***
2.33 (1.60–3.42) ***
Age groups
 25–34 years
Reference
Reference
 35–44 years
1.78 (1.11–2.83) *
1.83 (1.12–3.00) *
 45+ years
7.24 (4.88–10.74) ***
7.32 (4.78–11.21) ***
Race
 Non-Black African
Reference
Reference
 Black African
0.65 (0.39–1.07)
0.61 (0.33–1.13)
Employment status
 Unemployed
Reference
Reference
 Employed
0.68 (0.48–0.98) *
0.76 (0.50–1.15)
 Other (incl. Old age pensioner, sick/disabled and unable to work)
2.80 (1.45–5.40) **
2.27 (1.09–4.73) *
Locality
 Rural informal
Reference
Reference
 Rural (farms)
0.85 (0.51–1.42)
1.58 (0.86–2.90)
 Urban
1.44 (1.08–1.91) *
1.61 (1.16–2.23) **
Exposure to ARVs
 ARV naive
Reference
Reference
 ARV exposed
1.20 (0.85–1.68)
0.97 (0.67–1.40)
Hazardous alcohol consumption
 No risk
Reference
Reference
 Low risk
1.23 (0.88–1.71)
1.26 (0.83–1.93)
 Medium risk
0.47 (0.24–0.91) *
0.61 (0.29–1.30)
 High risk
1.78 (0.57–5.57)
4.43 (1.67–11.76) **
 Addiction likely
0.78 (0.31–1.94)
1.10 (0.43–2.78)
Diabetes
 No
Reference
Reference
 Yes
7.38 (4.41–12.35) ***
5.17 (2.69–9.96) ***
Heart disease
 No
Reference
Reference
 Yes
4.57 (2.35–8.88) ***
3.36 (1.59–7.10) **
*p < 0.05, **p < 0.01, ***p < 0.001

Factors associated with diabetes

The factors associated with diabetes in 2005 included being Black African (aOR = 5.70; 95% CI = 1.10 to 29.44) and those with hypertension (aOR = 11.71; 95% CI = 3.78 to 36.29) (Table 6). In 2008, factors associated with diabetes included the age group 45+ years (aOR = 4.44; 95% CI = 1.00 to 19.73), those who had hypertension (aOR = 7.56; 95% CI = 2.29 to 24.92) and those who had heart disease (aOR = 6.92; 95% CI = 1.62 to 29.62) (Table 7). While in 2017 factors associated with diabetes included the age group 45+ years (aOR = 7.90; 95% CI = 2.11 to 29.58), those who reported having poor health (aOR = 6.48; 95% CI = 1.65 to 25.41), those who had hypertension (aOR = 4.60; 95% CI = 2.34 to 9.07), those who had secondary and above education (aOR = 0.31; 95% CI = 0.16 to 0.59) and those who accessed public health care (aOR = 0.25; 95% CI = 0.11 to 0.60) (Table 8).
Table 6
Factors associated with diabetes for 2005
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
0.55 (0.22–1.39)
0.41 (0.14–1.20)
Age groups
 25–34 years
Reference
Reference
 35–44 years
1.00 (0.35–2.89)
0.88 (0.29–2.66)
 45+ years
1.32 (0.44–3.93)
0.58 (0.19–7.75)
Race
 Non-Black African
Reference
Reference
 Black African
3.77 (1.04–13.65) *
5.70 (1.10–29.44) *
Perception of general health
 Excellent
Reference
Reference
 Good
1.20 (0.15–9.78)
1.41 (0.26–7.62)
 Fair
5.91 (0.71–48.97)
5.16 (0.92–29.01)
 Poor
2.61 (0.25–27.00)
2.30 (0.33–16.05)
Hypertension
 No
Reference
Reference
 Yes
11.16 (4.14–30.05) ***
11.71 (3.78–36.29) ***
Mental distress
 No
Reference
Reference
 Yes
2.47 (0.93–6.54)
1.09 (0.40–2.92)
Health facility of choice
 Private
Reference
Reference
 Public
0.73 (0.25–2.14)
0.42 (0.15–1.11)
*p < 0.05, **p < 0.01, ***p < 0.001
Table 7
Factors associated with diabetes for 2008
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
2.31 (0.57–9.32)
1.28 (0.28–5.77)
Age groups
 25–34 years
Reference
Reference
 35–44 years
2.03 (0.46–8.98)
1.95 (0.43–8.86)
 45+ years
9.14 (2.67–31.27) **
4.44 (1.00–19.73) *
Race
 Non-African
Reference
Reference
 African
0.32 (0.08–1.35)
0.39 (0.09–1.81)
Hypertension
 No
Reference
Reference
 Yes
14.03 (5.27–37.35) ***
7.56 (2.29–24.92) ***
Heart disease
 No
Reference
Reference
 Yes
11.71 (3.02–45.39) ***
6.92 (1.62–29.62) **
*p < 0.05, **p < 0.01, ***p < 0.001
Table 8
Factors associated with diabetes for 2017
Variables in the model
Crude OR (95% CI)
Adjusted OR (95% CI)
Sex
 Male
Reference
Reference
 Female
1.47 (0.80–2.70)
1.80 (0.86–3.78)
Age groups
 25–34 years
Reference
Reference
 35–44 years
3.88 (1.01–14.93) *
6.38 (1.80–22.62) **
 45+ years
9.88 (2.96–32.95) ***
7.90 (2.11–29.58) **
Race
 Non-African
Reference
Reference
 African
0.54 (0.211–1.36)
0.52 (0.15–1.82)
Educational level
 None or Primary
Reference
Reference
 Secondary and above
0.22 (0.13–0.39) ***
0.31 (0.16–0.59) ***
Exposure to ARVs
 ARV naive
Reference
Reference
 ARV exposed
0.98 (0.54–1.77)
0.94 (0.47–1.85)
Perception of general health
 Excellent
Reference
Reference
 Good
2.18 (0.86–5.52)
1.15 (0.41–3.26)
 Fair
3.56 (1.30–9.81) *
1.04 (0.32–3.35)
 Poor
13.46 (4.63–39.15) ***
6.48 (1.65–25.41) **
Hypertension
 No
Reference
Reference
 Yes
7.38 (4.41–12.35) ***
4.60 (2.34–9.07) ***
Heart disease
 No
Reference
Reference
 Yes
1.79 (0.59–5.46)
0.77 (0.18–3.31)
Healthcare access
 Private
Reference
Reference
 Public
0.34 (0.17–0.70) **
0.25 (0.11–0.60) **
*p < 0.05, **p < 0.01, ***p < 0.001

Discussion

This study found an overall prevalence of hypertension among ALHIV in 2017 of 14.3%, and this was an increase since 2005. This hypertension prevalence is comparable to other African studies that also report estimates ranging between 10.2 and 17.4% [12, 18, 3436]. On the other hand, the overall prevalence of diabetes was 3.2% in 2017, which remained the same as in 2005 and 2008. This prevalence is lower than previously reported in other African countries with estimates ranging between 5.6 and 8.66% [1214, 20, 36, 37]. This may have been attributed to the participants not being aware of diabetes-related symptoms leading to the observed underestimation and this is supported by an IDF report stating that Africa has the highest proportion of undiagnosed diabetes [38]. Nevertheless, as PLHIV are more likely to interact with health facilities where hypertension screening is routine, case-finding and linkage to treatment can occur [39]. However different measures for diabetes will need to be implemented as routine vital checks at health facilities do not typically include diabetes tests unless patients have been recently diagnosed and appear “unwell” [39]. The findings also show that in 2005 most hypertensive and diabetic ALHIV were from the KwaZulu-Natal province. However, for 2017, the Gauteng province had the highest proportions of hypertensive and diabetic participants. Comparative studies to determine possible reasons for the shift from 2005 to 2017 could not be found at the time of this study. Nonetheless, according to the 2005 SABSSM survey, the KwaZulu-Natal province had a significantly higher number of PLHIV than the other provinces thus supporting our findings [28]. The shift in 2017 may have been due to urbanisation, migration and a rise in the elderly population which may be attributed to ART in PLHIV [40].
Our study also found that females, aged 45 years and older, and those who resided in an urban area had the highest prevalence of both NCDs for all 3 years. The high prevalence in women may be as a result of an underestimation in men reflecting more on their health-seeking behaviour than disease prevalence itself [14, 18, 34, 35, 41, 42]. The impact of urbanisation has also been documented in studies such as the 2012 SANHANES study and the South African cross-sectional study on HIV positive educators which suggest that urban living leads to easy access to unhealthy diets and a sedentary lifestyle [34, 35]. In 2008 and 2017, we further see that those who had primary education and below also had a high prevalence of hypertension and diabetes as supported by Ntuli et al. [43]. Wang et al. suggest that not only an unhealthy diet but even a lack of regular and effective physical exercise and higher alcohol intake can be correlated with low levels of schooling [44]. The presence of comorbidities was also evident with higher proportions of individuals with cancer, heart disease, TB and mental distress reporting having hypertension and diabetes. This is consistent with studies which observed similar findings globally and in Africa [34, 4547]. This could mean that PLHIV who have a comorbidity require close monitoring to ensure that their health conditions are effectively managed thereby reducing the risk of acquiring more NCDs.
Factors that increased the odds of hypertension for all 3 years in our study included being female, aged 45 years and older, or having diabetes. Antonello et al., Malaza et al., and Zungu et al. suggest that increased odds in females were mainly attributed to women having higher BMI’s and hip to weight ratios than men and women being more physically inactive, all of which are considered risk factors [35, 41, 48]. Ageing has also been well described to result in gradual vascular stiffening and the prolonged use of ART particularly protease inhibitors is related to the production of vascular reactive oxygen species resulting in hypertension [17, 23, 24]. While diabetes has been suggested by Petrie et al., and Gazzaruso et al. to result from hypertension-linked insulin resistance due to multiple pathophysiological mechanisms influencing microvascular and endothelial functioning [24, 25]. Mental distress also increased the odds of having high blood pressure in 2005. An American study found that one’s mental health affects one’s ability to maintain a healthy lifestyle, seek early treatment for comorbid conditions, or consistently adhere to treatment programs [45]. Living in an urban area was another significant factor associated with hypertension in 2008 and 2017. Findings from previous studies suggest that urbanisation and the associated lifestyle change including poor diet and low physical activity are risk factors of hypertension [49]. While having a high risk of hazardous alcohol consumption or having heart disease were also additional associated factors for hypertension found in 2017. In Zimbabwean and Brazilian studies alcohol consumption increased the risk of hypertension, however, there have been several hypotheses proposed for this association [50, 51]. Some researchers have to an extent been able to characterize the pathogenesis due to harmful alcohol drinking, citing that a reduction in vasodilators like nitric oxide occurs leading to an inflammatory lack of relaxation and oxidative injury of the blood vessel lining [52]. Other researchers have suggested the link between harmful alcohol consumption and the eventual accumulation of triglycerides and total cholesterol, both of which have been documented to have a link to hypertension [53]. In addition, according to the WHO, heart disease can result from hypertension in the general population [54]. Hypertension and diabetes have long been documented to be a major modifiable risk factor for heart disease due to the progressive damage to the heart that occurs over time [55, 56]. Lastly, in 2017, the employment category “other” which included pensioners, sick and disabled people, was also associated with hypertension. The reasoning for this includes that pensioners are presumably older hence the effect of age may have attributed to this finding; also, sick and disabled people are more likely to be non-mobile and be physically inactive both of which again are characteristics that have been documented to increase the risk of hypertension.
The common significant factor associated with diabetes across the years was having hypertension and the supporting reasons and studies are identical to those mentioned above. In 2008 other additional factors included being 45 years and above and having heart disease; both established risk factors in other studies [49]. In 2017, being 45 years and above, and reporting poor health was significantly associated with diabetes in the study population. Also, having secondary and above education level lowered one’s odds of having diabetes. Other studies with a similar finding reported that education increased awareness and therefore the individuals were more likely to make better health-related decisions [18]. The above findings from our study, thus, offer various avenues for possible interventions which may include active awareness campaigns targeted at men, those who have educational qualifications below secondary level or those residing in urban areas. Also, as the HIV population is ageing, closely monitoring the impact of antiretroviral medication could be considered. Lastly, these findings could allow for the refinement of the integrated chronic care model allowing for increased case finding.

Limitations

This study had a few limitations. Due to the cross-sectional nature of the surveys, causality cannot be determined in the study population. Questionnaire data used were self-reported and therefore prone to social desirability, recall bias and underreporting. The analysis did not account for unmeasured and unreported risk factors and other confounders that may have had an impact on the outcome variables. Also, as hypertension and diabetes were not measured or diagnostically determined, misclassification bias may have been introduced. Lastly, wide confidence intervals for some variables were observed and this may have been as a result of a small sample answering particular questions, therefore, conclusions drawn from the data need to be replicated with a larger sample size. Nevertheless, the surveys were nationally representative and can be generalised to adults aged 25 years and above living with HIV with hypertension and diabetes.

Conclusion

Population-based nationally representative surveys are important for developing sound health decisions and policies that would affect the country. This study identified factors consistently associated with the prevalence of hypertension and diabetes among ALHIV overtime. Additional contemporary risk factors were also identified. Therefore, these findings contribute to understanding the trend and identifying modifiable factors responsible for hypertension and diabetes among ALHIV adults from 2005 to 2017. This may help inform the development of integrated chronic disease management model to reduce the co-morbid burden of disease and associated adverse health outcomes.

Acknowledgements

Not applicable.

Declarations

Ethical clearance for the secondary analysis was obtained from the University of the Witwatersrand Human Research Ethics Committee (certificate M191181). Ethical approval for the primary studies was obtained from the HSRC Research Ethics Committee (2005 certificate REC: 5/24/05/04; 2008 certificate REC: 2/23/10/07; 2017 certificate REC: 4/18/11/15) and the USA’s Centers for Disease Control and Prevention (CDC). Voluntary informed written consent was submitted by all individuals who agreed to participate in the studies. All methods were performed in accordance with the relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Simbayi LC, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017. Cape Town: HSRC Press; 2019. Simbayi LC, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017. Cape Town: HSRC Press; 2019.
4.
5.
Zurück zum Zitat Joint United Nations Programme on HIV/AIDS. Chronic care of HIV and non-communicable diseases: how to leverage the HIV experience. Geneva: UNAIDS; 2011. Joint United Nations Programme on HIV/AIDS. Chronic care of HIV and non-communicable diseases: how to leverage the HIV experience. Geneva: UNAIDS; 2011.
6.
Zurück zum Zitat Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS. 2018;32(Suppl 1):S5–S20.PubMedCrossRef Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS. 2018;32(Suppl 1):S5–S20.PubMedCrossRef
7.
Zurück zum Zitat Kamkuemah M, Gausi B, Oni T. Missed opportunities for NCD multimorbidity prevention in adolescents and youth living with HIV in urban South Africa. BMC Public Health. 2020;20(1):821.PubMedPubMedCentralCrossRef Kamkuemah M, Gausi B, Oni T. Missed opportunities for NCD multimorbidity prevention in adolescents and youth living with HIV in urban South Africa. BMC Public Health. 2020;20(1):821.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet. 2008;372(9642):893–901.PubMedPubMedCentralCrossRef Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet. 2008;372(9642):893–901.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Erzse A, Stacey N, Chola L, Tugendhaft A, Freeman M, Hofman K. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Glob Health Action. 2019;12(1):1636611.PubMedPubMedCentralCrossRef Erzse A, Stacey N, Chola L, Tugendhaft A, Freeman M, Hofman K. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study. Glob Health Action. 2019;12(1):1636611.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa. Circulation. 2005;112(23):3569–76.PubMedCrossRef Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa. Circulation. 2005;112(23):3569–76.PubMedCrossRef
11.
Zurück zum Zitat Todowede OO, Mianda SZ, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—a systematic review and meta-analysis. Syst Rev. 2019;8(1):4.PubMedPubMedCentralCrossRef Todowede OO, Mianda SZ, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—a systematic review and meta-analysis. Syst Rev. 2019;8(1):4.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Ataro Z, Ashenafi W, Fayera J, Abdosh T. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia. Hiv Aids (Auckl). 2018;10:181–92.PubMedCentral Ataro Z, Ashenafi W, Fayera J, Abdosh T. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia. Hiv Aids (Auckl). 2018;10:181–92.PubMedCentral
13.
Zurück zum Zitat Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study. BMJ Open. 2018;8(7):e019664.PubMedPubMedCentralCrossRef Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study. BMJ Open. 2018;8(7):e019664.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Magodoro IM, Esterhuizen TM, Chivese T. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe. BMC Res Notes. 2016;9:379.PubMedPubMedCentralCrossRef Magodoro IM, Esterhuizen TM, Chivese T. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe. BMC Res Notes. 2016;9:379.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, et al. Diabetes mellitus in Zambia and the Western cape province of South Africa: prevalence, risk factors, diagnosis and management. Diabetes Res Clin Pract. 2016;118:1–11.PubMedPubMedCentralCrossRef Bailey SL, Ayles H, Beyers N, Godfrey-Faussett P, Muyoyeta M, du Toit E, et al. Diabetes mellitus in Zambia and the Western cape province of South Africa: prevalence, risk factors, diagnosis and management. Diabetes Res Clin Pract. 2016;118:1–11.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Gbadamosi MA, Tlou B. Prevalence of abnormal glucose metabolism among adults attending an outpatient department at a tertiary referral hospital in Swaziland: a cross-sectional study. BMC Public Health. 2020;20(1):392.PubMedPubMedCentralCrossRef Gbadamosi MA, Tlou B. Prevalence of abnormal glucose metabolism among adults attending an outpatient department at a tertiary referral hospital in Swaziland: a cross-sectional study. BMC Public Health. 2020;20(1):392.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Peck RN, Shedafa R, Kalluvya S, Downs JA, Todd J, Suthanthiran M, et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014;12(1):125.PubMedPubMedCentralCrossRef Peck RN, Shedafa R, Kalluvya S, Downs JA, Todd J, Suthanthiran M, et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med. 2014;12(1):125.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016;11(5):e0156309.PubMedPubMedCentralCrossRef Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016;11(5):e0156309.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Magula NP, Motala AA, Lalloo UG. The prevalence and incidence of diabetes mellitus and other disorders of glycaemia in south African black patients on antiretroviral therapy. Int J Infect Dis. 2014;21:10.CrossRef Magula NP, Motala AA, Lalloo UG. The prevalence and incidence of diabetes mellitus and other disorders of glycaemia in south African black patients on antiretroviral therapy. Int J Infect Dis. 2014;21:10.CrossRef
20.
Zurück zum Zitat Prioreschi A, Munthali RJ, Soepnel L, Goldstein JA, Micklesfield LK, Aronoff DM, et al. Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis. BMJ Open. 2017;7(3):e013953.PubMedPubMedCentralCrossRef Prioreschi A, Munthali RJ, Soepnel L, Goldstein JA, Micklesfield LK, Aronoff DM, et al. Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis. BMJ Open. 2017;7(3):e013953.PubMedPubMedCentralCrossRef
22.
23.
Zurück zum Zitat Fahme SA, Bloomfield GS, Peck R. Hypertension in HIV-infected adults: novel pathophysiologic mechanisms. Hypertension. 2018;72(1):44–55.PubMedCrossRef Fahme SA, Bloomfield GS, Peck R. Hypertension in HIV-infected adults: novel pathophysiologic mechanisms. Hypertension. 2018;72(1):44–55.PubMedCrossRef
24.
Zurück zum Zitat Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84.PubMedCrossRef Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84.PubMedCrossRef
25.
Zurück zum Zitat Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21(7):1377–82.PubMedCrossRef Gazzaruso C, Bruno R, Garzaniti A, Giordanetti S, Fratino P, Sacchi P, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21(7):1377–82.PubMedCrossRef
26.
Zurück zum Zitat Mutyambizi C, Chola L, Groot W, Pavlova M, Labadarios D, Hongoro C. The extent and determinants of diabetes and cardiovascular disease comorbidity in South Africa – results from the south African National Health and nutrition examination survey (SANHANES-1). BMC Public Health. 2017;17(1):745.PubMedPubMedCentralCrossRef Mutyambizi C, Chola L, Groot W, Pavlova M, Labadarios D, Hongoro C. The extent and determinants of diabetes and cardiovascular disease comorbidity in South Africa – results from the south African National Health and nutrition examination survey (SANHANES-1). BMC Public Health. 2017;17(1):745.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 2016;16(1):1243.PubMedPubMedCentralCrossRef Divala OH, Amberbir A, Ismail Z, Beyene T, Garone D, Pfaff C, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 2016;16(1):1243.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Shisana ORT, Simbayi LC, Parker W, Zuma K, Bhana A, Connolly C, Jooste S, Pillay V, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2005. Cape Town: HSRC Press; 2005. Shisana ORT, Simbayi LC, Parker W, Zuma K, Bhana A, Connolly C, Jooste S, Pillay V, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2005. Cape Town: HSRC Press; 2005.
29.
Zurück zum Zitat Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Pillay-van-Wyk V, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers? Cape Town: HSRC Press; 2009. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Pillay-van-Wyk V, et al. South African national HIV prevalence, incidence, behaviour and communication survey 2008: a turning tide among teenagers? Cape Town: HSRC Press; 2009.
30.
Zurück zum Zitat Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. 2014. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. 2014.
31.
Zurück zum Zitat Reid MC, Fiellin DA, O'Connor PG. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999;159(15):1681–9.PubMedCrossRef Reid MC, Fiellin DA, O'Connor PG. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999;159(15):1681–9.PubMedCrossRef
32.
Zurück zum Zitat StataCorp. Stata Statistical Software: Release 15. College Station: StataCorp LLC; 2017. StataCorp. Stata Statistical Software: Release 15. College Station: StataCorp LLC; 2017.
34.
Zurück zum Zitat Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A, et al. The south African National Health and nutrition examination survey, 2012: SANHANES-1: the health and nutritional status of the nation. 2014. Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A, et al. The south African National Health and nutrition examination survey, 2012: SANHANES-1: the health and nutritional status of the nation. 2014.
35.
Zurück zum Zitat Zungu NP, Mabaso ML, Kumalo F, Sigida S, Mlangeni L, Wabiri N, et al. Prevalence of non-communicable diseases (NCDs) and associated factors among HIV positive educators: findings from the 2015/6 survey of health of educators in public schools in South Africa. PLoS One. 2019;14(2):e0209756.PubMedPubMedCentralCrossRef Zungu NP, Mabaso ML, Kumalo F, Sigida S, Mlangeni L, Wabiri N, et al. Prevalence of non-communicable diseases (NCDs) and associated factors among HIV positive educators: findings from the 2015/6 survey of health of educators in public schools in South Africa. PLoS One. 2019;14(2):e0209756.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat van Heerden A, Barnabas RV, Norris SA, Micklesfield LK, van Rooyen H, Celum C. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa. J Int AIDS Soc. 2017;20(2):e25012.PubMedCentralCrossRef van Heerden A, Barnabas RV, Norris SA, Micklesfield LK, van Rooyen H, Celum C. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa. J Int AIDS Soc. 2017;20(2):e25012.PubMedCentralCrossRef
37.
Zurück zum Zitat Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA. Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx. NY J Urban Health. 2011;88(3):507–16.PubMedCrossRef Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA. Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx. NY J Urban Health. 2011;88(3):507–16.PubMedCrossRef
39.
Zurück zum Zitat Knowledge Translation Unit UoCTLI. Adult primary care guide (APC) 2019/2020. Pretoria: The National Department of Health of South Africa; 2019. Knowledge Translation Unit UoCTLI. Adult primary care guide (APC) 2019/2020. Pretoria: The National Department of Health of South Africa; 2019.
40.
Zurück zum Zitat StatsSA. Statistics South Africa. Formal census. 2011. StatsSA. Statistics South Africa. Formal census. 2011.
41.
Zurück zum Zitat Antonello VS. Carlos Ferreira Antonello I, Grossmann TK, Tovo CV, Brasil dal Pupo B, de Quadros Winckler L. hypertension—an emerging cardiovascular risk factor in HIV infection. J Am Soc Hypertens. 2015;9(5):403–7.PubMedCrossRef Antonello VS. Carlos Ferreira Antonello I, Grossmann TK, Tovo CV, Brasil dal Pupo B, de Quadros Winckler L. hypertension—an emerging cardiovascular risk factor in HIV infection. J Am Soc Hypertens. 2015;9(5):403–7.PubMedCrossRef
42.
Zurück zum Zitat da Cunha GH, Franco KB, Galvão MTG, Lima MAC, Fontenele MSM, Siqueira LR, et al. Diabetes mellitus in people living with HIV/AIDS: prevalence and associated risk factors. AIDS Care. 2020;32(5):600–7.PubMedCrossRef da Cunha GH, Franco KB, Galvão MTG, Lima MAC, Fontenele MSM, Siqueira LR, et al. Diabetes mellitus in people living with HIV/AIDS: prevalence and associated risk factors. AIDS Care. 2020;32(5):600–7.PubMedCrossRef
43.
Zurück zum Zitat Ntuli ST, Maimela E, Alberts M, Choma S, Dikotope S. Prevalence and associated risk factors of hypertension amongst adults in a rural community of Limpopo Province, South Africa. Afr J Prim Health Care Fam Med. 2015;7(1):847.PubMedPubMedCentralCrossRef Ntuli ST, Maimela E, Alberts M, Choma S, Dikotope S. Prevalence and associated risk factors of hypertension amongst adults in a rural community of Limpopo Province, South Africa. Afr J Prim Health Care Fam Med. 2015;7(1):847.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Wang Y, Chen J, Wang K, Edwards CL. Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. J Hum Hypertens. 2006;20(11):898–900.PubMedCrossRef Wang Y, Chen J, Wang K, Edwards CL. Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. J Hum Hypertens. 2006;20(11):898–900.PubMedCrossRef
45.
Zurück zum Zitat Ojike N, Sowers JR, Seixas A, Ravenell J, Rodriguez-Figueroa G, Awadallah M, et al. Psychological distress and hypertension: results from the National Health Interview Survey for 2004-2013. Cardiorenal Med. 2016;6(3):198–208.PubMedPubMedCentralCrossRef Ojike N, Sowers JR, Seixas A, Ravenell J, Rodriguez-Figueroa G, Awadallah M, et al. Psychological distress and hypertension: results from the National Health Interview Survey for 2004-2013. Cardiorenal Med. 2016;6(3):198–208.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Schutte AE, Ware LJ, Huisman HW, Fourie CMT, Greeff M, Khumalo T, et al. Psychological distress and the development of hypertension over 5 years in black south Africans. J Clin Hypertens. 2015;17(2):126–33.CrossRef Schutte AE, Ware LJ, Huisman HW, Fourie CMT, Greeff M, Khumalo T, et al. Psychological distress and the development of hypertension over 5 years in black south Africans. J Clin Hypertens. 2015;17(2):126–33.CrossRef
47.
Zurück zum Zitat World Health Organization. Global report on diabetes, vol. 2016. Geneva: World Health Organization; 2016. World Health Organization. Global report on diabetes, vol. 2016. Geneva: World Health Organization; 2016.
48.
Zurück zum Zitat Malaza A, Mossong J, Bärnighausen T. Newell M-L. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS One. 2012;7(10):e47761.PubMedPubMedCentralCrossRef Malaza A, Mossong J, Bärnighausen T. Newell M-L. Hypertension and obesity in adults living in a high HIV prevalence rural area in South Africa. PLoS One. 2012;7(10):e47761.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018;6(3):208–22.PubMedPubMedCentralCrossRef Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018;6(3):208–22.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Chireshe R, Naidoo K, Nyamakura R. Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa hospital: a descriptive study. Afr J Prim Health Care Fam Med. 2019;11(1):e1–8.PubMedCrossRef Chireshe R, Naidoo K, Nyamakura R. Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa hospital: a descriptive study. Afr J Prim Health Care Fam Med. 2019;11(1):e1–8.PubMedCrossRef
51.
Zurück zum Zitat Ikeda MLR, Barcellos NT, Alencastro PR, Wolff FH, Moreira LB, Gus M, et al. Alcohol drinking pattern: a comparison between HIV-infected patients and individuals from the general population. PLoS One. 2016;11(6):e0158535.PubMedPubMedCentralCrossRef Ikeda MLR, Barcellos NT, Alencastro PR, Wolff FH, Moreira LB, Gus M, et al. Alcohol drinking pattern: a comparison between HIV-infected patients and individuals from the general population. PLoS One. 2016;11(6):e0158535.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Husain K, Ferder L, Ansari RA, Lalla J. Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum Exp Toxicol. 2011;30(8):930–9.PubMedCrossRef Husain K, Ferder L, Ansari RA, Lalla J. Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum Exp Toxicol. 2011;30(8):930–9.PubMedCrossRef
53.
Zurück zum Zitat Hao G, Wang Z, Zhang L, Chen Z, Wang X, Guo M, et al. Relationship between alcohol consumption and serum lipid profiles among middle-aged population in China: a multiple-center cardiovascular epidemiological study. Angiology. 2015;66(8):753–8.PubMedCrossRef Hao G, Wang Z, Zhang L, Chen Z, Wang X, Guo M, et al. Relationship between alcohol consumption and serum lipid profiles among middle-aged population in China: a multiple-center cardiovascular epidemiological study. Angiology. 2015;66(8):753–8.PubMedCrossRef
55.
Zurück zum Zitat Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–92.PubMedCrossRef Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–92.PubMedCrossRef
56.
Zurück zum Zitat Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246–58.PubMedPubMedCentralCrossRef Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246–58.PubMedPubMedCentralCrossRef
Metadaten
Titel
Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005–2017
verfasst von
Nicola Chiwandire
Nompumelelo Zungu
Musawenkosi Mabaso
Charles Chasela
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2021
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-021-10502-8

Weitere Artikel der Ausgabe 1/2021

BMC Public Health 1/2021 Zur Ausgabe